Search Results - "MacDonagh, Lauren"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways by Leon, Gemma, MacDonagh, Lauren, Finn, Stephen P, Cuffe, Sinead, Barr, Martin P

    Published in Pharmacology & therapeutics (Oxford) (01-02-2016)
    “…Lung cancer is the leading cause of cancer mortality worldwide. Despite advances in anti-cancer therapies such as chemotherapy, radiotherapy and targeted…”
    Get full text
    Journal Article
  2. 2

    The emerging role of microRNAs in resistance to lung cancer treatments by MacDonagh, Lauren, Gray, Steven G, Finn, Stephen P, Cuffe, Sinead, O’Byrne, Kenneth J, Barr, Martin P

    Published in Cancer treatment reviews (01-02-2015)
    “…Highlights • MicroRNAs (miRNAs) are small, non-coding RNAs that post-transcriptionally control the translation and stability of mRNAs. • It has been predicted…”
    Get full text
    Journal Article
  3. 3

    Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin by MacDonagh, Lauren, Santiago, Rhyla Mae, Gray, Steven G., Breen, Eamon, Cuffe, Sinead, Finn, Stephen P., O'Byrne, Kenneth J., Barr, Martin P.

    Published in Translational oncology (01-04-2021)
    “…•All-trans retinoic acid (ATRA) and retinol significantly reduced ALDH1+ve cell subsets.•Co-treatment of ATRA or retinol with cisplatin significantly inhibited…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Lung cancer stem cells: The root of resistance by MacDonagh, Lauren, Gray, Steven G, Breen, Eamon, Cuffe, Sinead, Finn, Stephen P, O'Byrne, Kenneth J, Barr, Martin P

    Published in Cancer letters (28-03-2016)
    “…Highlights • Therapeutic resistance and tumor recurrence is common in lung cancer. • Cancer stem cells (CSCs) have the ability to self-renew and differentiate…”
    Get full text
    Journal Article
  6. 6

    BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC by MacDonagh, Lauren, Gray, Steven G., Breen, Eamon, Cuffe, Sinead, Finn, Stephen P., O'Byrne, Kenneth J., Barr, Martin P.

    Published in Cancer letters (01-08-2018)
    “…Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related deaths worldwide. While partial or complete tumor regression can be achieved in…”
    Get full text
    Journal Article
  7. 7

    Efficacy and adherence of noninvasive ventilation treatment in children with Down syndrome by MacDonagh, Lauren, Farrell, Lisa, O'Reilly, Ruth, McNally, Paul, Javadpour, Sheila, Cox, Des W.

    Published in Pediatric pulmonology (01-06-2021)
    “…Objective Children with Down syndrome (DS) have an increased prevalence of obstructive sleep apnea (OSA). Noninvasive ventilation (NIV) is a common modality of…”
    Get full text
    Journal Article
  8. 8

    Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC by MacDonagh, Lauren, Gallagher, Michael F, Ffrench, Brendan, Gasch, Claudia, Breen, Eamon, Gray, Steven G, Nicholson, Siobhan, Leonard, Niamh, Ryan, Ronan, Young, Vincent, O'Leary, John J, Cuffe, Sinead, Finn, Stephen P, O'Byrne, Kenneth J, Barr, Martin P

    Published in Oncotarget (22-09-2017)
    “…Non-small cell lung cancer (NSCLC) accounts for a large proportion of cancer deaths and is characterized by low treatment response rates and poor overall…”
    Get full text
    Journal Article
  9. 9

    Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma by Cregan, Sian, Breslin, Maeve, Roche, Gerard, Wennstedt, Sigrid, MacDonagh, Lauren, Albadri, Cinaria, Gao, Yun, O'Byrne, Kenneth J, Cuffe, Sinead, Finn, Stephen P, Gray, Steven G

    Published in International journal of oncology (01-03-2017)
    “…Malignant pleural mesothelioma (MPM) is a rare aggressive cancer of the pleura primarily associated with prior exposure to asbestos. The current standard of…”
    Get full text
    Journal Article
  10. 10